These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 18776468)

  • 1. Influence of 3'-azido-2',3'-dideoxyguanosine treatment on amounts of TERT and POT1 in human HL60 cells.
    Liu X; Ogawara T; Kurashina Y; Saneyoshi M; Yamaguchi T
    Nucleic Acids Symp Ser (Oxf); 2008; (52):491-2. PubMed ID: 18776468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of 3'-azido-2',3'-dideoxyguanosine treatment on telomere length in human telomerase-immortalized human fibroblast cells.
    Kurashina Y; Liu X; Kato C; Inoue N; Saneyoshi M; Yamaguchi T
    Nucleic Acids Symp Ser (Oxf); 2009; (53):249-50. PubMed ID: 19749354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of nucleoside analogue treatment on telomere length and TRF2 amount in human HL60 cells.
    Liu X; Liu J; Ogawara T; Kurashina Y; Yashi R; Saneyoshi M; Yamaguchi T
    Nucleic Acids Symp Ser (Oxf); 2007; (51):253-4. PubMed ID: 18029682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
    Kelleher C; Kurth I; Lingner J
    Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere shortening in human HL60 cells by treatment with deoxyguanosine analogs.
    Yamaguchi T; Takahashi H; Harada Y; Yoshikawa M; Iyono S; Inomata M; Maruyama T; Saneyoshi M
    Nucleic Acids Symp Ser (Oxf); 2004; (48):187-8. PubMed ID: 17150541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere shortening in human HL60 cells by treatment with 3'-azido-2',3'-dideoxynucleosides and telomerase inhibition by their 5'-triphosphates.
    Liu X; Inomata M; Ogawara T; Saneyoshi M; Yamaguchi T
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1067-71. PubMed ID: 18058538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.
    Liu X; Takahashi H; Harada Y; Ogawara T; Ogimura Y; Mizushina Y; Saneyoshi M; Yamaguchi T
    Nucleic Acids Res; 2007; 35(21):7140-9. PubMed ID: 17942424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POT1 as a terminal transducer of TRF1 telomere length control.
    Loayza D; De Lange T
    Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
    Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTOP interacts with POT1 and regulates its localization to telomeres.
    Liu D; Safari A; O'Connor MS; Chan DW; Laegeler A; Qin J; Songyang Z
    Nat Cell Biol; 2004 Jul; 6(7):673-80. PubMed ID: 15181449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase inhibition by 3'-azido-2', 3'-dideoxynucleoside 5'-triphosphates and telomere shortening in human cultured cells by the corresponding nucleosides.
    Yamaguchi T; Liu X; Ogawara T; Inomata M; Saneyoshi M
    Nucleic Acids Symp Ser (Oxf); 2006; (50):271-2. PubMed ID: 17150922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
    Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
    Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against chromosome degradation at the telomeres.
    Grandin N; Charbonneau M
    Biochimie; 2008 Jan; 90(1):41-59. PubMed ID: 17764802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere length homeostasis requires that telomerase levels are limiting.
    Cristofari G; Lingner J
    EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
    Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
    Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two faces of Solanaceae telomeres: a comparison between Nicotiana and Cestrum telomeres and telomere-binding proteins.
    Peska V; Sýkorová E; Fajkus J
    Cytogenet Genome Res; 2008; 122(3-4):380-7. PubMed ID: 19188709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of long-term treatment with cytosine arabinoside on telomere length in human HL60 cells.
    Yamaguchi T; Kazama K; Takashima J; Ogawara T; Iyono S; Inomata M; Saneyoshi M
    Nucleic Acids Symp Ser (Oxf); 2005; (49):289-90. PubMed ID: 17150747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere length and regulatory proteins in human skeletal muscle with and without ongoing regenerative cycles.
    Ponsot E; Echaniz-Laguna A; Delis AM; Kadi F
    Exp Physiol; 2012 Jun; 97(6):774-84. PubMed ID: 22366562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of telomere length by the human telomeric protein TRF1.
    van Steensel B; de Lange T
    Nature; 1997 Feb; 385(6618):740-3. PubMed ID: 9034193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection.
    Lei M; Podell ER; Cech TR
    Nat Struct Mol Biol; 2004 Dec; 11(12):1223-9. PubMed ID: 15558049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.